Reaction
Drug Monitoring Procedure Incorrectly Performed reporting signals
As of the last recalculation, Drug Monitoring Procedure Incorrectly Performed appears in 659 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is TOLVAPTAN (PRR 99.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tolvaptan | 43 | 99.9 | 100.2 |
| Niraparib | 48 | 73.6 | 73.8 |
| Cabotegravir | 15 | 60.0 | 60.1 |
| Esketamine Hydrochloride | 28 | 51.8 | 51.8 |
| Aripiprazole | 130 | 41.5 | 41.6 |
| Aripiprazole Oral | 45 | 36.8 | 36.9 |
| Aripiprazole Orally Disintegrating | 45 | 36.8 | 36.9 |
| Febuxostat Tablets 40 Mg | 10 | 31.5 | 31.6 |
| Febuxostat Tablets 80 Mg | 10 | 31.5 | 31.6 |
| Febuxostat | 10 | 19.1 | 19.1 |
| Fingolimod Hcl | 33 | 12.6 | 12.6 |
| Clozapine | 42 | 11.2 | 11.2 |